Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
July 10, 2007
Integration of inositol phosphate signaling pathways via human ITPK1
Philip P Chamberlain, Xun Qian, Amanda R Stiles, et al.
Nature Structural & Molecular Biology
|
April 7, 2020
Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex
Mary E Matyskiela, Thomas Clayton, Xinde Zheng, et al.
Science (New York, N.Y.)
|
November 15, 2022
Molecular glue CELMoD compounds are regulators of cereblon conformation
Edmond R Watson, Scott Novick, Mary E Matyskiela, et al.
ACS Chemical Biology
|
November 18, 2020
Cereblon Modulators Target ZBTB16 and Its Oncogenic Fusion Partners for Degradation via Distinct Structural Degrons
Mary E Matyskiela, Jinyi Zhu, Joshua M Baughman, et al.
Journal of Medicinal Chemistry
|
July 31, 2008
Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitors
Jingshan Ren, Philip P Chamberlain, Anna Stamp, et al.
Blood
|
January 14, 2021
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
Sarah Gooding, Naser Ansari-Pour, Fadi Towfic, et al.
Nature Communications
|
September 2, 2021
Structure of the human marker of self 5-transmembrane receptor CD47
Gustavo Fenalti, Nicolas Villanueva, Mark Griffith, et al.
Journal of Medicinal Chemistry
|
April 21, 2017
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
Mary E Matyskiela, Weihong Zhang, Hon-Wah Man, et al.
Nature Structural & Molecular Biology
|
August 11, 2014
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P Chamberlain, Antonia Lopez-Girona, Karen Miller, et al.
Nature Chemical Biology
|
September 8, 2018
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate
Mary E Matyskiela, Suzana Couto, Xinde Zheng, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
July 10, 2007
Integration of inositol phosphate signaling pathways via human ITPK1
Philip P Chamberlain, Xun Qian, Amanda R Stiles, et al.
Nature Structural & Molecular Biology
|
April 7, 2020
Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex
Mary E Matyskiela, Thomas Clayton, Xinde Zheng, et al.
Science (New York, N.Y.)
|
November 15, 2022
Molecular glue CELMoD compounds are regulators of cereblon conformation
Edmond R Watson, Scott Novick, Mary E Matyskiela, et al.
ACS Chemical Biology
|
November 18, 2020
Cereblon Modulators Target ZBTB16 and Its Oncogenic Fusion Partners for Degradation via Distinct Structural Degrons
Mary E Matyskiela, Jinyi Zhu, Joshua M Baughman, et al.
Journal of Medicinal Chemistry
|
July 31, 2008
Structural basis for the improved drug resistance profile of new generation benzophenone non-nucleoside HIV-1 reverse transcriptase inhibitors
Jingshan Ren, Philip P Chamberlain, Anna Stamp, et al.
Blood
|
January 14, 2021
Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma
Sarah Gooding, Naser Ansari-Pour, Fadi Towfic, et al.
Nature Communications
|
September 2, 2021
Structure of the human marker of self 5-transmembrane receptor CD47
Gustavo Fenalti, Nicolas Villanueva, Mark Griffith, et al.
Journal of Medicinal Chemistry
|
April 21, 2017
A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos
Mary E Matyskiela, Weihong Zhang, Hon-Wah Man, et al.
Nature Structural & Molecular Biology
|
August 11, 2014
Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs
Philip P Chamberlain, Antonia Lopez-Girona, Karen Miller, et al.
Nature Chemical Biology
|
September 8, 2018
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate
Mary E Matyskiela, Suzana Couto, Xinde Zheng, et al.
Page
of 3